Principal Financial Group’s Relmada Therapeutics RLMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2022
Q4
Sell
-6,870
Closed -$255K 2526
2022
Q3
$255K Buy
+6,870
New +$255K ﹤0.01% 2136